Application 021830

Type
NDA
Sponsor
APIL

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ASACOL HDMESALAMINETABLET, DELAYED RELEASE;ORAL800MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0023-5901Asacol HDmesalamineAllergan, Inc.NDACurrent
0023-5901Asacol HDmesalamineAllergan, Inc.NDACurrent
0023-5901Asacol HDmesalamineAllergan, Inc.NDACurrent
0023-5901Asacol HDmesalamineAllergan, Inc.NDACurrent
0023-5901Asacol HDmesalamineAllergan, Inc.NDACurrent
0023-5901Asacol HDmesalamineAllergan, Inc.NDACurrent
0023-5901Asacol HDmesalamineAllergan, Inc.NDACurrent
0023-5901Asacol HDmesalamineAllergan, Inc.NDACurrent
0430-0783ASACOL HDmesalamineAllergan, Inc.NDACurrent
50090-3497mesalaminemesalamineA-S Medication SolutionsNDA AUTHORIZED GENERICCurrent
50090-3497mesalaminemesalamineA-S Medication SolutionsNDA AUTHORIZED GENERICCurrent
50090-3497mesalaminemesalamineA-S Medication SolutionsNDA AUTHORIZED GENERICCurrent
59762-0117MESALAMINEMESALAMINEGreenstone LLCNDACurrent
60687-347mesalaminemesalamineAmerican Health PackagingNDA AUTHORIZED GENERICCurrent
68382-484mesalaminemesalamineZydus Pharmaceuticals (USA) Inc.NDA AUTHORIZED GENERICCurrent
68382-649mesalaminemesalamineZydus Pharmaceuticals (USA) Inc.NDA AUTHORIZED GENERICCurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
72645SUPPL2022-11-17
72627SUPPL2022-11-17
69194SUPPL2021-11-02
69183SUPPL2021-11-02
64849SUPPL2020-10-06
64800SUPPL2020-10-02
64107SUPPL2020-07-28
53769SUPPL2018-04-23
53742SUPPL2018-04-19
49139SUPPL2017-07-28
49125SUPPL2017-07-28
16431SUPPL2016-05-06
6275SUPPL2016-05-06
37734SUPPL2013-10-22
28674SUPPL2013-10-21
37733SUPPL2012-05-14
28673SUPPL2010-05-28
21837ORIG2009-05-15
37732SUPPL2009-04-28
28672SUPPL2009-04-27
24220ORIG2008-07-17
37731ORIG2008-06-12
28671ORIG2008-06-03
51336SUPPL1900-01-01
51335SUPPL1900-01-01
51334SUPPL1900-01-01